Board of Directors and Management

image description

Simon Cottle

Chairman and CEO
Career Highlights:
  • Mr. Cottle serves as the Chairman and Chief Executive Officer of HAIA
  • He is a Founding Partner at Stanley Capital and a Board Member of Noden Pharma. Mr. Cottle has originated and led the Noden Pharma and Essential deals since at Stanley
  • Mr. Cottle’s lead investor experience was as a Managing Director and IC member at Ardian and Director at Hg Capital. At Ardian and HgCapital Mr. Cottle led or co-led deals into Parts Alliance, GSF, DDS Software, Zenith, Leasedrive, Trigo and Envision Pharma. He was named as one of the top 40 under 40 private equity practitioners in the inaugural Financial News awards in 2013
  • Mr. Cottle’s pre investing background was as an investment banker at Deutsche Bank and Citigroup, a technology and healthcare management consultant at Arthur D Little. He was a British Olympian in the Athens Olympic Games in 2004 (Rowing) and holds an MBA (INSEAD) and an MA (Oxford) where he was a Richard Blackwell Scholar and multiple College Prize winner in 1997 and 1998. Before university he held an IBM Scholarship in Computer Science where he helped program early voice recognition software
Background:
  • Managing Director and IC member – Ardian Buyout
  • Director – HgCapital
image description

Patrick Hargutt

CFO
Career Highlights:
  • Mr. Hargutt serves as the Chief Financial Officer and a member of the board of directors of HAIA
  • He is a Founding Partner at Stanley Capital and a Board Member of Noden Pharma. Mr. Hargutt is a private equity and special situations investor with a strong track record across both equity and debt transactions
  • Prior to Stanley Capital, Mr. Hargutt was an investor at Centerbridge Partners and Monarch Alternative Capital. He started his career as an investment banker at JP Morgan
  • Mr. Hargutt holds a Masters in Mathematics at the Technical University Munich with summa cum laude. He is the author of the mathematical specialist book “A Fractional Heath-Jarrow-Morton Approach for Interest Rate Markets“, published while on a post-graduate research scholarship at Imperial College London
Background:
  • Vice – President – Monarch Alternative Capital
  • Centerbridge Partners
  • JP Morgan
image description

James Brooks

Director
Career Highlights:
  • Mr. Brooks serves as a member of the board of directors of HAIA
  • He is a Founding Partner at Stanley Capital and co-led the investment into Noden Pharma
  • James is a Special Advisor to Shell for energy transition execution strategies. Until September 2021 he was on the leadership team of Shell’s R&ES division, responsible for strategy and investment decision making for platforms across power, e-mobility, hydrogen, carbon offsets and venture investing
  • From 2016 – 2020, Mr. Brooks co-led the rapid growth of Lightsource BP to become a global leader in the renewable energy sector. In that same period, he founded, raised and worked as Managing Partner of one of the world’s largest emerging market-focused green private equity funds, Eversource Capital, and completed investments across utility scale and distributed energy, mobility, water and waste management sectors
  • Prior to joining Lightsource BP, Mr. Brooks was co-head of EMEA Energy and UK & Ireland for Goldman Sachs’s Merchant Banking Division, its principal investment platform. Prior to GS, he worked at First Reserve and Advent International
  • Mr. Brooks holds a Masters and BA degree in Physics from Merton College, University of Oxford
Background:
  • Strategy Director – Lightsource BP
  • Co-head EMEA Energy and UK – Goldman Sachs Merchant Banking
  • Director – First Reserve
  • Director – Advent

image description

Greg Caswill

Director
Career Highlights:
  • Mr. Caswill has agreed to serve as a member of the board of directors of HAIA
  • He is the current Chairman and founder of Envision Pharma, a leading provider of scientific data communication services and technology solutions to biopharmaceutical and medical devices companies
  • Mr. Caswill has more than 30 years of experience in pharmaceutical services outsourcing notably as a former founder member and
    finance director of a specialist medical communications agency
  • Mr. Caswill is a chartered accountant by background
Background:
  • Chairman Envision Pharma
image description

Xavier Flinois

Director
Career Highlights:
  • Mr. Flinois has agreed to serve as a member of the board of directors of HAIA
  • Mr. Flinois serves as founder and CEO of Houat Invest, an investment consultancy. He is also a director of Actigraph, a provider of wearable technology solutions for clinical research
  • Mr. Flinois was the President of Parexel Informatics, one of the leading technology providers to the biopharmaceutical and medical industry for the development and commercialization of new medical therapies. He served as a member of the management board and director of publicly listed Schlumberger, the largest Oilfield Services company worldwide and of Atos a leading European IT Services provider. Mr Flinois is a former CEO of Clinical Solutions, a UK-based provider of cloud-based clinical decision support systems for the urgent and pandemic healthcare markets
  • Additionally, Mr.Flinois was previously a director at UK engineering and electronics manufacturer Data Marine Systems and at AtosEuronext Market Solutions, a joint-venture between Atos and EuroNext in the financial technology sector
  • Mr. Flinois was recognized as one of the 2016 ComputerWorld Premier 100 Technology Leaders and one of the 2018 PharmaVoice 100 most inspiring people in the life Science Industry
  • Xavier is an Ecole Polytechnique graduate
Background:
  • Ex CEO of Parexel Informatics
image description

Rob Piconi

Career Highlights:
  • Mr. Piconi has agreed to serve as a member of the board of directors of HAIA
  • Mr. Piconi serves as the CEO, co-founder and shareholder of renewable energy startup Energy Vault, Inc. He is also the chairman of medical devices company Chronos Imaging LLC
  • Mr. Piconi has over 25 years of experience in executive roles in diverse industries, including CEO and managing director of medical equipment service group MESA Group Holdings GmbH and the Founder and Group CEO of Pantheon Healthcare, now branded as Althea Group
  • Prior to this, Mr. Piconi was an executive operator, entrepreneur, and investor with a primary sector focus in Healthcare (diagnostic medical devices, radiology, and clinical services), Network Telecommunications and Sustainability (diversified energy, utility scale renewable energy storage) demonstrating a strong track of value creation and successful exits
  • He was the president and group executive of the network management and security platform (Communications Group) of US based diagnostic imaging device, science and technology conglomerate Danaher Corporation (NYSE: DHR). Prior to that, he was president, managing director and CEO of a medical device equipment and service portfolio company of Boston-based private
    equity firm Berkshire Partners LLC
  • Mr. Piconi held executive leadership roles within the Network Telecommunications sector at Bell Labs Lucent Technologies (now Nokia) and UK based Spirent Communications
  • In 2020, he was one of 15 global leaders named by the World Economic Forum as “SDG Champion” for his work advancing sustainability, decarbonization and the circular economy
  • He holds an MBA from Northwestern University (Kellogg School of Management) and a BBA in Finance and Italian Renaissance Literature from the University of Notre Dame
Background:
  • CEO Energy Vault
  • Founder and ex Group CEO of Pantheon Healthcare
image description

Elizabeth Weymouth

Career Highlights:
  • Ms. Weymouth has agreed to serve as a member of the board of directors of HAIA
  • She is the Founder, Managing Partner and Chair of the Investment Committee member at Grafine Partners, LP and an independent director of Queen’s Gambit Growth Capital
  • Prior to founding Grafine Partners in 2018, Ms. Weymouth served as a Partner at Riverstone Holdings LLC, a private investment firm focused on growth capital investments in the energy industry, from 2007 to 2017, where Ms. Weymouth helped to institutionalize the firm and secured $27 billion of capital from global sources
  • Before joining Riverstone Holdings LLC, Ms. Weymouth was at J.P. Morgan serving in a variety of roles from 1994 to 2007, including serving as Managing Director at J.P. Morgan Private Bank and Head of Investments for the U.S. Northeast region, as well as serving on the Global Investment Leadership Team and Fiduciary Oversight Committee
  • Ms. Weymouth additionally served as a member of the firm’s Senior Women’s Leadership Forum and Mentoring Committee
  • Earlier in her career, Ms. Weymouth worked in London for Willis Corroon, PLC as an Associate in the Oil and Gas Division, negotiating insurance coverage for Fortune 50 energy companies with underwriters
  • Ms. Weymouth additionally served as Chair of the board of trustees of the University of Virginia Darden School of Business from 2016 to 2019, where she served as the first female chair in their history
  • She holds an MBA. from the Darden Graduate School of Business and a BA from the University of Virginia
Background:
  • Managing Partner Grafine Partners